Lactulose
NDC 18124-002, Lactulose, solution, from Fresenius Kabi Austria GmbH.
- Product NDC
- 18124-002
- Status
- Listed
- Labeler
- Fresenius Kabi Austria GmbH
- Dosage form
- SOLUTION
- Route
- ORAL, RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090502
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/18124-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACTULOSE10 g/15mL
Pharmacologic classes
Acidifying Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 18124-002-16 | 18124000216 | 473 mL in 1 BOTTLE (18124-002-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a89835c9-8ce5-4627-8d7d-70ff175b2e07
Use it
Look up 18124-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/18124-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 18124-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.